01-Oct-2020 - Julius-Maximilians-Universität Würzburg

A cancer shredder

A new compound for treating cancer: It destroys a protein that triggers its development

The villain in this drama has a pretty name: Aurora – Latin for dawn. In the world of biochemistry, however, Aurora (more precisely: Aurora-A kinase) stands for a protein that causes extensive damage. There, it has been known for a long time that Aurora often causes cancer. It triggers the development of leukemias and many pediatric cancers, such as neuroblastomas.

Researchers at the universities of Würzburg and Frankfurt have now developed a drug that can disarm Aurora. Dr. Elmar Wolf, biochemist and research group leader at the Biocenter of Julius-Maximilians-Universität Würzburg (JMU), and Stefan Knapp, Professor of Pharmaceutical Chemistry at Goethe University Frankfurt, have played a leading role in this development. The results of their work have now been published in the latest issue of Nature Chemical Biology.

Making tumor-promoting proteins disappear

“Cancers are usually triggered by tumorigenic proteins,” explains Elmar Wolf. Because cancer cells produce more of these proteins than normal cells, the dynamics are additionally increased. A common therapeutic approach is therefore to inhibit the function of these proteins with drugs. “Although the proteins are then still there, they no longer function as well. This makes it possible to combat the tumor cells,” he says.

However, the development of these inhibitors is difficult and has so far not been successful for all tumor-promoting proteins. To date, none of the candidates that inhibit Aurora has shown the desired results in clinical practice. The dream of many scientists is therefore to develop a drug that not only inhibits the tumor-promoting proteins but makes them disappear completely. A promising approach along this path could be a new class of substances with the scientific name “PROTAC”.

In vitro cancer cells die

“We have developed such a PROTAC for Aurora,” says Elmar Wolf. Together with his team and especially his doctoral student Bikash Adhikari, he was able to show that this PROTAC completely degrades the Aurora protein in cancer cells. Such cells cultivated in the laboratory died as a result.

Wolf describes the mode of action of this substance as follows: “The tumor needs certain tumor-promoting proteins, which we can imagine as the pages of a book. Our PROTAC substance tears out the ‘Aurora’ pages and destroys them with the help of the machinery that every cell has to degrade old and broken proteins.” PROTAC thus “shreds” the Aurora protein, as it were, until nothing of it remains.

Further work is required

Professor Stefan Knapp from the Institute of Pharmaceutical Chemistry at Goethe University explains: “Aurora-A kinase is present in much higher concentrations in many cancer tissues than in healthy tissue and it also plays a key role in prostate cancer. Blocking the activity of Aurora-A kinase alone seems not a promising approach as none of the many clinically tested drug candidateshas achieved clinical approval. With our PROTAC variant, we inhibit Aurora-A kinase via another, possibly more effective mechanism, which may open up new treatment options. That’s why in the next step we’ll test effectiveness and tolerance in animal models.”

  • Bikash Adhikari et al.; "PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase"; Nature Chemical Biology; 28.09.2020.
Facts, background information, dossiers
More about Uni Würzburg
  • News

    Small RNA as a Central Player in Infections

    More than half of the world's population carries the bacterium Helicobacter pylori in their stomach mucosa. It often causes no problems throughout life, but sometimes it can cause inflammation, and in some cases, it can even lead to the development of stomach cancer. Helicobacter pylori use ... more

    New Strategy Against Osteoporosis

    Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women and one in five men aged over 50 suffer from osteoporotic bone fractures. Osteoporosis is caused by excessive activity of bone resorb ... more

    Hurdle of microscopy overcome

    High-resolution microscopy makes it theoretically possible to image cell structures with a resolution of a few nanometres. However, this has not yet been possible in practice. The reason for this is that antibodies carrying a fluorescent dye are usually used to mark the cell structures. The ... more

More about Uni Frankfurt am Main
  • News

    Possible Achilles’ heel of SARS-CoV-2 virus identified

    When the SARS-CoV-2 virus penetrates human cells, it lets the human host cell produce proteins for it. One of these viral proteins, called PLpro, is essential for the replication and rapid spread of the virus. An international team of researchers led by Goethe University and University Hosp ... more

    How smart, ultrathin nanosheets go fishing for proteins

    An interdisciplinary team from Frankfurt and Jena has developed a kind of bait with which to fish protein complexes out of mixtures. Thanks to this “bait”, the desired protein is available much faster for further examination in the electron microscope. The research team has christened this ... more

    Division of labour on the surface of bacteria

    Bacteria of the species Thermus thermophilus possess two types of extensions on their surface (pili) for the purpose of motion and for capturing and absorbing DNA from their environment. This has been discovered by researchers at Goethe University together with researchers in Great Britain. ... more